JCI
44
2
STI
15
-5
JPM
71
2
AAL
50
2
BIIB
45
-3
NWL
35
-4
MTCH
44
-2
AIV
62
-2
GT
49
-3
FCX
67
14
ZION
55
2
MCK
73
2
MS
70
-2
NKE
39
2
APA
30
5
MAC
71
-4
ALLE
37
-4
MDLZ
46
-4
MAS
51
-11
L
63
3
JCI
44
2
STI
15
-5
JPM
71
2
AAL
50
2
BIIB
45
-3
NWL
35
-4
MTCH
44
-2
AIV
62
-2
GT
49
-3
FCX
67
14
ZION
55
2
MCK
73
2
MS
70
-2
NKE
39
2
APA
30
5
MAC
71
-4
ALLE
37
-4
MDLZ
46
-4
MAS
51
-11
L
63
3
Financhill
Back

Mitsubishi 10K Form

Sell
44

MSBHF
Mitsubishi

Last Price:
21.67
Seasonality Move:
4.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MSBHF News And Ratings

See the #1 stock for the next 7 days that we like better than MSBHF

MSBHF Financial Statistics

Sales & Book Value

Annual Sales: $135.6B
Cash Flow: $1.57B
Price / Cash Flow: 16.4
Annual Sales: $14.58
Price / Book: 1.49

Profitability

EPS (TTM): 1.54570
Net Income (TTM): $6.71B
Gross Margin: $16.35B
Return on Equity: 9.96%
Return on Assets: 4.22%

Mitsubishi Earnings Forecast

Key Mitsubishi Financial Ratios

  • The Gross Profit Margin over the past 19 years for MSBHF is 12.06%.
  • The Selling, General & Administrative Expenses for MSBHF have been equal to 8.65% of Gross Profit Margin.
  • The Research & Development expenses have been 0.09% of Revenue.
  • The Interest Expense is 19.83% of Operating Income.
  • The Net Earning history of MSBHF is 4.93% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 10 years.

Mitsubishi Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Trading Companies & Distributors
Sector: Industrials
Current Symbol: MSBHF
Website: mitsubishicorp.com

Debt

Debt-to-Equity Ratio: 0.57
Current Ratio: 1.44
Quick Ratio: 0.72

Price-to-Earnings

Trailing P/E Ratio: 14.06
Forward P/E Ratio: 0

MSBHF Technical Analysis vs Fundamental Analysis

Sell
44
Mitsubishi (MSBHF) is a Sell

Is Mitsubishi a Buy or a Sell?

  • Mitsubishi stock is rated a Sell
    The current Mitsubishi [MSBHF] share price is $21.67. The Score for MSBHF is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.